• NeoGrid expands supply chain services: 3 things to know

    NeoGrid, a Chicago-based provider of supply chain management solutions, partnered with the Brazilian startup Lett Insights to expand its offering of supply chain services.  By Mackenzie Bean -
  • Four key takeaways from the 2016 AHRMM Conference

    Our nation’s health systems remain focused on evolving in the face of change. The Association for Healthcare Resource & Materials Management (AHRMM) Conference is always a great opportunity to gain insights into some of the industry’s most innovative approaches to improving healthcare delivery.
  • Prescription drug costs see largest jump in 24 years

    Americans spent 7 percent more money on prescription drugs in 2016 than in 2015, presenting the largest increase since 1992, according to a report from the Bureau of Labor Statistics.  By Mackenzie Bean -
  • Texas Medical Center partners with J&J to develop medical devices

    Johnson & Johnson Innovation will open a facility dedicated to expediting the development of "breakthrough" medical devices at Houston-based Texas Medical Center.  By Mackenzie Bean -
  • FDA OKs Roche's Tecentriq for lung cancer patients

    The Food and Drug Administration approved Roche's bladder cancer drug Tecentriq as a second-line treatment for patients with metastatic non-small cell lung cancer.  By Mackenzie Bean -
  • Tenn. high school opens medical device machinery lab

    Bartlett (Tenn.) High School recently opened a Machine Tool Tech Lab on campus where students can learn how to use machinery to make medical devices, reports The Commercial Appeal.  By Mackenzie Bean -
  • Sen. Blumenthal urges DOJ to reject Mylan settlement

    Sen. Richard Blumenthal (D-Conn.) sent a letter to the Department of Justice Monday, urging the entity to reject a recent settlement with Canonsburg, Pa.-based drugmaker Mylan.  By Mackenzie Bean -
  • TPC names ROi preferred supply chain partner: 3 things to know

    TPC — a network of independent healthcare providers and regional purchasing coalition based in Plano, Texas — will partner with Resource Optimization & Innovation, a provider-owned group purchasing organization based in St. Louis.  By Mackenzie Bean -
  • Supply chain tip of the week: Use the 80/20 rule

    When searching for savings opportunities, it is wise to sort your item master file using the Pareto principle, also known as the 80/20 rule, says John Mateka, MBA, MHA, interim director of materials management for Florence, S.C.-based McLeod Health.  By Mackenzie Bean -
  • Pfizer to launch biosimilar version of J&J's Remicade in Nov.

    New York City-based Pfizer will start shipping its biosimilar copy of Johnson & Johnson's best-selling arthritis drug Remicade in November, offering the drug at a 15 percent discount, according to Reuters.  By Mackenzie Bean -
  • Abbott, St. Jude Medical will sell devices to Terumo for $1.1B

    Abbott Park, Ill.-based Abbott Laboratories and Saint Paul, Minn.-based St. Jude Medical — which Abbott is in the process of acquiring for $25 billion — plan to sell several medical devices to Japan-based Terumo for about $1.1 billion, reports Reuters.  By Mackenzie Bean -
  • CMS' competitive bidding program may cut back on device fraud, says GAO

    The number of Medicare beneficiaries receiving durable medical equipment items decreased after the implementation of a competitive bidding program, possibly from a reduction in device fraud, according to a recent report from the U.S. Government Accountability Office.  By Mackenzie Bean -
  • FDA greenlights Teleflex's new catheter

    Wayne, Pa.-based device maker Teleflex earned Food and Drug Administration approval for its Arrow Midline catheter.  By Mackenzie Bean -
  • FDA approves Genentech's eye drug

    The Food and Drug Administration recently approved the use of a prefilled syringe as an acceptable delivery method for the drug Lucentis.  By Mackenzie Bean -
  • How one Bernie Sanders tweet cost this drug company $387M

    Ariad Pharmaceutical investors lost $387 million Friday following a tweet from Sen. Bernie Sanders' (I-Vt.) twitter account that called out the drug company for its high prices in front of an audience of 2.6 million followers, reported The Next Web.  By Mackenzie Bean -
  • Medical technology sales to hit $500B within 5 years: 4 takeaways

    The global medical device and technology market will surpass $500 billion in sales by 2021, according to a recent analysis from the London-based research firm Evaluate.  By Mackenzie Bean -
  • 4 thoughts Americans have on drone deliveries

    Three-fourths of Americans expect to see the implementation of drone deliveries within the next five years, according to a new study by United States Postal Service Office of Insepector General.  By Mackenzie Bean -
  • Why 3PLS should not panic about supply chain disruptors

    Third-party logistics providers should not be concerned about technology solution providers looking to upend traditional supply chain models, according to Thorsten Meincke, senior vice president of global sea freight at Kuehne + Nagel, a major logistics and transportation company based in Feusisberg, Switzerland.  By Mackenzie Bean -
  • Huge accident payouts push insurers away from trucking industry

    Insurers are distancing themselves from the transportation industry amidst a trend of multimillion-dollar accident payouts, leaving trucking companies scrambling to find coverage for their fleets, reported The Wall Street Journal.  By Mackenzie Bean -
  • How to ensure effective supply chain practices amidst a shifting reimbursement landscape

    Controlling spend on high value supplies is more crucial than ever as the healthcare industry shifts from fee-for-service to value-based care.  By Mackenzie Bean -
  • Drug industry reaps new profits from opioid abuse crisis

    As the U.S. grapples with the nation-wide opioid abuse epidemic, pharmaceutical companies are seizing on the opportunity to expand profits by providing medications to relieve the negative side effects of other drugs, according to The Washington Post. By Tamara Rosin -

Top 40 Articles from the Past 6 Months